Demonstrates that cholesterol metabolites can either drive or inhibit breast cancer, highlighting risks that treatments could disrupt this delicate balance.
Cholesterol metabolites can promote or suppress breast cancer, raising questions about how therapies might disrupt this balance.
No takes yet. Share an insight, caveat, or question.
Silvente‐Poirot et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: